NEW YORK and SUZHOU, China, Sept. 13, 2026 /PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced that AC-101 tablets have been included in the Rare Diseases Innovative Drug Development Encouragement Pilot Program (the "Caring Plan-Extension", known...
Hence then, the article about accro bioscience announces inclusion of ac 101 tablets in the nmpa cde s caring plan extension pilot program for rare disease drug development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development )
Also on site :
- AI’s real bottleneck is electricity. Who will pay for it?
- Noah Wyle Says Eddie Murphy Told Him to ‘F— Off’ When He Was 9 Years Old, So ‘The Pitt’ Star Always Signs Autographs for Kids Now
- Stora Enso's Board of Directors approves demerger plan to separate Bergslagets Skogar into a new listed company, announcing strategic targets and dividend policy